In silico toxicity prediction of 1-phenyl-1-(quinazolin-4-yl) ethanol compounds by using Toxtree, pkCSM and preADMET

Authors

DOI:

https://doi.org/10.12928/pharmaciana.v8i2.9508

Keywords:

toxicity prediction, in silico, 1-phenyl-1-(quinazolin-4-yl) ethanols, Toxtree, pkCSM, PreADMET

Abstract

The 1-phenyl-1-(quinazolin-4-yl) ethanol compounds are alkaloids of quinozoline class found in many Hydrangeaceae families. A survey revealed that most of the identified quinazolin derivatives have anticancer activity. Toxicity prediction of 1-phenyl-1-(quinazolin-4-yl) ethanols were performed to obtain the best three compounds with high activity and the lowest toxicity. Toxicity prediction was conducted using Toxtree, pkCSM and PreADMET. 2D structure of compounds were formed using ChemDraw. The decision tree approach was used in Toxtree application with endpoints including Cramer rules, Kroes TTC, carcinogenicity (genotoxic and non genotoxic) and in vitro mutagenicity. Graph based signature was used in pkCSM application with endpoints including mutagenicity, maximum daily dose, LD50 and hepatotoxicity. In PreADMET application, a method based on drugs similarity and ADMET properties was used with endpoints including mutagenicity, carcinogenicity to rat and mice. The results of data analysis showed that the best three anticancer compounds that have high activity and the lowest toxicity are compounds 14, 16 and 19.

References

Ajani, O. O., Aderohunmu, D. V., Umeokoro, E. N. and Olomieja, A. O., 2016, Quinazoline Pharmacophore in Therapeutic Medicine, Bangladesh Journal of Pharmacology, 11(3): 716–733.

Benigni, R., Bossa, C., Jeliazkova, N., Netzeva, T. and Worth, A., 2008, The Benigni/Bossa Rulebase for Mutagenicity and Carcinogenicity–A Module of Toxtree. JRC Scientific and Technical Reports, Retrieved from http://ihcp.jrc.ec.europa.eu/our_labs/ computational_toxicology/doc/EUR_23241_EN.pdf.

Faraj, F.L., Zahedifard, M., Paydar, M., Looi, C.Y., Abdul Majid, N., Ali, H.M., Ahmad, N., Gwaram, N.S., Abdulla, M.A., Faraj, F.L., Zahedifard, M., Paydar, M., Looi, C.Y., Abdul Majid, N., Ali, H.M., Ahmad, N., Gwaram, N.S., Abdulla, M.A., 2014, Synthesis, Characterization, and Anticancer Activity of New Quinazoline Derivatives against MCF-7 Cells. The Scientific World Journal.

Kuroiwa, K., Ishii, H., Matsuno, K., Asai, A. and Suzuki, Y., 2015, Synthesis and Structure-Activity Relationship Study of 1-phenyl-1-(quinazolin-4-yl)ethanols as Anticancer Agents. ACS Medicinal Chemistry Letters, 6(3): 287–291.

Lipinski, C. A., Lombardo, F., Dominy, B. W. and Feeney, P. J., 2012, Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and development Settings, Advanced Drug Delivery Reviews, 64(SUPPL.): 4–17.

Parameshwar, R., Harinadha Babu, V., Manichandrika, P., Narendra Sharath Chandra, J. N. and Swetha, K., 2016, Design, Synthesis, In Silico Toxicity Prediction, Molecular Docking, and Evaluation of Novel Pyrazole Derivatives as Potential Antiproliferative Agents, EXCLI Journal, 15: 187–202.

Pires, D. E. V., Blundell, T. L. and Ascher, D. B., 2015, pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures. Journal of Medicinal Chemistry, 58(9): 4066–4072.

Priyanto, 2015, Toksikologi, Mekanisme, Terapi Antidotum, dan Penilaian Resikoi. Depok: Lembaga Studi dan Konsultasi Farmakologi (Leskonfi).

Raies, A. B. and Bajic, V. B., 2016, In Silico Toxicology: Computational Methods for the Prediction of Chemical Toxicity, Wiley Interdisciplinary Reviews: Computational Molecular Science, 147–172.

Riju, A., Sithara, K., Nair, S. S. and Eapen, S. J., 2010, Prediction of Toxicity and Pharmacological Potential of Selected Spice Compounds. In Proceedings of the International Symposium on Biocomputing - ISB ’10, 1.

Valerio, L. G., 2009, In Silico Toxicology for the Pharmaceutical Sciences. Toxicology and Applied Pharmacology, 241(3): 356–370.

Veber, D. F., Johnson, S. R., Cheng, H., Smith, B. R., Ward, K. W. and Kopple, K. D., 2002, Molecular Properties that Influence the Oral Bioavailability of Drug Candidates, Journal of Medicinal Chemistry, 45: 2615–2623.

Wulandari and Kristin, E., 2010, Tesis Analisis Interaksi Histone Deacetylase (HDAC) Kelas II Homo Sapiens dengan Suberoyllanilide Hydroxamic Acids (SAHA) dan Trichostatin A (TSA). Depok: Fakultas Matematika dan Ilmu Pengetahuan Alam UI.

Zhang, L., Ai, H., Chen, W., Yin, Z., Hu, H., Zhu, J., Zhao, J., Zhao, Q., Liu, H., 2017, CarcinoPred-EL: Novel Models for Predicting the Carcinogenicity of Chemicals Using Molecular Fingerprints and Ensemble Learning Methods, Scientific Reports, 7(1).

Downloads

Published

2018-11-24

Issue

Vol. 8 No. 2 (2018): Pharmaciana

Section

Analytical Pharmacy and Medicinal Chemistry

License

Authors who publish with Pharmaciana agree to the following terms:

  1. Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal. 
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.